...
首页> 外文期刊>Basic & clinical pharmacology & toxicology. >Effects of nimesulide, acetylsalicylic acid, ibuprofen and nabumetone on cyclooxygenase-1- and cyclooxygenase-2-mediated prostanoid production in healthy volunteers ex vivo.
【24h】

Effects of nimesulide, acetylsalicylic acid, ibuprofen and nabumetone on cyclooxygenase-1- and cyclooxygenase-2-mediated prostanoid production in healthy volunteers ex vivo.

机译:尼美舒利,乙酰水杨酸,布洛芬和萘丁美酮对健康志愿者体内环氧合酶-1-和环氧合酶-2介导的前列腺素生成的影响。

获取原文
获取原文并翻译 | 示例

摘要

: The beneficial actions of non-steroidal anti-inflammatory drugs (NSAIDs) have been associated with inhibition of cyclooxygenase-2 (COX-2), whereas some of their adverse effects are associated mainly with inhibition of COX-1. Selective COX-2 inhibitors reduce the risk of gastrointestinal adverse events, but increase the risk of thromboembolic events pointing to importance of optimal COX-1/COX-2 inhibition in drug safety. We compared the effects of acetylsalicylic acid, ibuprofen, nabumetone and nimesulide on COX-1 and COX-2 pathways in healthy volunteers in an ex vivo set-up using single oral doses commonly used to treat acute pain. In a randomized, double-blind four-phase cross-over study, 15 healthy volunteers were given orally a single dose of either acetylsalicylic acid 500 mg, ibuprofen 400 mg, nabumetone 1 g or nimesulide 100 mg. Blood samples were drawn before and 1, 3, 6, 24 and 48 hr after the drug for the assessment of COX-1 and COX-2 activity. COX-1 activity was measured as thromboxane(2) production during blood clotting and COX-2 activity as endotoxin-induced prostaglandin E(2) synthesis in blood leucocytes. The data show that after a single oral dose these four NSAIDs have different profiles of action on COX-1 and COX-2. As expected, acetylsalicylic acid appeared to be COX-1-selective and ibuprofen effectively inhibited both COX-1 and COX-2. Nabumetone showed only a slight inhibitory effect on COX-1 and COX-2. Nimesulide caused almost complete suppression of COX-2 activity and a partial reduction of COX-1 activity. This confirms the relative COX-2 selectivity of nimesulide.
机译::非甾体类抗炎药(NSAIDs)的有益作用与抑制环氧合酶2(COX-2)有关,而它们的某些不良作用则主要与抑制COX-1有关。选择性COX-2抑制剂可降低胃肠道不良事件的风险,但会增加血栓栓塞事件的风险,这表明最佳COX-1 / COX-2抑制在药物安全性中的重要性。我们使用通常用于治疗急性疼痛的单次口服剂量,在离体实验中比较了健康志愿者中乙酰水杨酸,布洛芬,萘丁美酮和尼美舒利对COX-1和COX-2途径的影响。在一项随机,双盲,四阶段交叉研究中,对15名健康志愿者口服了单剂量的乙酰水杨酸500 mg,布洛芬400 mg,萘丁美酮1 g或尼美舒利100 mg。在药物之前和之后1、3、6、24和48小时抽取血样,以评估COX-1和COX-2活性。 COX-1活性被测定为凝血过程中的血栓烷(2)产生,COX-2活性被测定为内毒素诱导的血白细胞中前列腺素E(2)的合成。数据显示,单次口服后,这四种NSAID对COX-1和COX-2的作用不同。如预期的那样,乙酰水杨酸似乎是COX-1选择性的,布洛芬可有效抑制COX-1和COX-2。萘丁美酮对COX-1和COX-2的抑制作用很小。尼美舒利几乎完全抑制了COX-2活性,部分降低了COX-1活性。这证实了尼美舒利的相对COX-2选择性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号